Wasoff Evan L 4
4 · NEXIEN BIOPHARMA, INC. · Filed Aug 21, 2020
Insider Transaction Report
Form 4
Wasoff Evan L
Chief Financial Officer
Transactions
- Award
Options to purchase common stock (right to buy)
2020-08-19+1,500,000→ 1,500,000 totalExercise: $0.08From: 2020-08-19Exp: 2027-08-19→ Common Stock (1,500,000 underlying)
Holdings
- 1,000,000
Common Stock
- 200,000
Stock option - right to buy
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (200,000 underlying) - 420,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (420,000 underlying)
Footnotes (2)
- [F1]Options to purchase 1,000,000 shares are vested and immediately exercisable. Options to purchase 500,000 shares vest over 4 quarters beginning September 30, 2020.
- [F2]Granted in lieu of cash compensation.